Artiva Biotherapeutics (ARTV) Cash & Current Investments (2023 - 2026)
Artiva Biotherapeutics' Cash & Current Investments came in at $349.4 million for Q2 2026, up 145.4% from $142.4 million a year earlier and up 302.5% from the prior quarter.
Powered by 
Analysis
Artiva Biotherapeutics (ARTV) Cash & Current Investments (2023 - 2026) Analysis & Trends
At the end of FY2025, Artiva Biotherapeutics' Cash & Current Investments was $108 million, down 41.7% from FY2024.
- Going back by year, Cash & Current Investments was $185.4 million in FY2024 (+140.9%) and $76.97 million in FY2023.
- The Q2 2026 figure represents the highest quarterly Cash & Current Investments in data going back to Q2 2023.
- Year-over-year, Cash & Current Investments increased in five of the last eight quarters, with growth averaging 101.5%.
- The fastest year-over-year change in Cash & Current Investments over five years came in Q1 2025 (growth of 244.4%), and the weakest in Q1 2026 (a decline of 47.7%).
- Business Quant data shows ARTV's Cash & Current Investments at $86.8 million (Q1 2026), $108 million (Q4 2025) and $123 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Artiva Biotherapeutics | 242.39 Mn | -107.01 Mn | - | 349.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 349.40 Mn |
| Mar 31, 2026 | 86.80 Mn |
| Dec 31, 2025 | 108.00 Mn |
| Sep 30, 2025 | 123.00 Mn |
| Jun 30, 2025 | 142.40 Mn |
| Mar 31, 2025 | 166.00 Mn |
| Dec 31, 2024 | 185.40 Mn |
| Sep 30, 2024 | 199.60 Mn |
| Jun 30, 2024 | 46.56 Mn |
| Mar 31, 2024 | 48.20 Mn |
| Dec 31, 2023 | 76.97 Mn |
| Sep 30, 2023 | 65.89 Mn |
| Jun 30, 2023 | 53.70 Mn |
API Access
Artiva Biotherapeutics Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ARTV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "ARTV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ARTV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();